Welcome to Making it Happen: Deprescribing Education Program
This program was developed after consultation with many stakeholders, including patients, healthcare providers, and policymakers, who identified a need for an interprofessional deprescribing education program for healthcare providers and students.
This program is aimed at nurse practitioners, pharmacists, physicians, and registered nurses working in primary care practice and students in nursing, medicine, and pharmacy.
Development and Acknowledgements:
The project was started by the Optimizing Therapy Through Collaboration (OPTx) Team led by Dr. Jennifer Isenor and Dr. Natalie Kennie-Kaulbach at the College of Pharmacy at Dalhousie University.
Content developers for the modules were: Isaac Bai, Eden d’Entremont-MacVicar, Dr. Jennifer Isenor, Dr. Natalie Kennie-Kaulbach, and Dr. Shanna Trenaman.
Deprescribing Champions who shared their experiences in module videos were: Eden d’Entremont-MacVicar, Dr. Alethea Lacas, and Cheryl Smith.
Website and course development were supported by Hannah Gormley, Ella Kim, and Emma Ramsay, who were pharmacy students at the College of Pharmacy, Dalhousie University at the time of program development.
The project was supported by many colleagues throughout, including Sarah Burgess, Dr. Sarah Burm, Dr. Christine Cassidy, Olga Kits, Dr. Ruth Martin-Misener, Dr. Jill McSweeney-Flaherty, Dr. Emily Reeve, and Dr. Shanna Trenaman.
We would like to thank the following people who reviewed the program at various times and provided invaluable feedback: Samy Barsum, Dr. Lisa Bonang, Bridgette Chan, Eden d’Entremont-MacVicar, Melanie Dunlop, Dr. Elizabeth Gillis, Kori Hamilton, Dr. Kathleen Horrey, and Cheryl Smith.
The project was funded through a grant from the Dalhousie Pharmacy Endowment Fund. It was launched in collaboration with the Canadian Medication Appropriateness and Deprescribing Network (DeprescribingNetwork.ca).
If you have any questions or comments on this educational program, you may contact the Canadian Medication Appropriateness and Deprescribing Network team at info@caden-recad.ca
Course Features
- Lectures 33
- Quiz 0
- Duration Lifetime access
- Skill level All levels
- Language English
- Students 205
- Certificate Yes
- Assessments Yes
Curriculum
- 6 Sections
- 33 Lessons
- Lifetime
- Module 1: Introduction3
- Module 2: Why Deprescribing Matters6
- 2.1Learning Objective 1: Define deprescribing and how this relates to optimal prescribing.
- 2.2Learning Objective 2: Explain the benefits of deprescribing from a patient, safety, societal, and healthcare provider perspective.
- 2.3Learning Objective 3: Explain how deprescribing can be supported through interprofessional collaboration.
- 2.4Learning Objective 4: Describe the systematic, step-wise, evidence-informed approach to deprescribing that is used in the program.
- 2.5Learning Objective 5: Identify common barriers and facilitators to deprescribing
- 2.6Module 2 Reference List
- Module 3: Identify Deprescribing Opportunities and Your Role5
- 3.1Learning Objective 1: Identify opportunities to deprescribe, including common medications and patient situations, and recognize when to not deprescribe.
- 3.2Learning Objective 2: Describe key strategies for collecting a medication history to support deprescribing.
- 3.3Learning Objective 3: Utilize available screening tools and resources that may be used to identify deprescribing opportunities.
- 3.4Learning Objective 4: Recognize ways that deprescribing can be implemented within the context of your role and in relation to other healthcare providers who can support the process.
- 3.5Module 3 Reference List
- Module 4: Supporting Deprescribing Decisions6
- 4.1Learning Objective 1: Identify and weigh the benefits and risks of deprescribing a medication.
- 4.2Learning Objective 2: Elicit patient preferences, values, and goals when deprescribing.
- 4.3Learning Objective 3: Describe strategies to initiate a conversation about deprescribing between patients and providers.
- 4.4Learning Objective 4: Apply available deprescribing resources to help facilitate deprescribing decisions.
- 4.5Learning Objective 5: Identify potential patient barriers and facilitators to deprescribing.
- 4.6Module 4 Reference List
- Module 5: Develop and Share the Deprescribing Plan6
- 5.1Learning Objective 1: Identify and prioritize deprescribing options including non-drug therapy.
- 5.2Learning Objective 2: Determine the best dosing approach to deprescribing a medication.
- 5.3Learning Objective 3: Identify components of a complete deprescribing plan and create a deprescribing plan for a case scenario.
- 5.4Learning Objective 4: Communicate the deprescribing plan with the patient/caregiver and other healthcare providers who can support the deprescribing process.
- 5.5Learning Objective 5: Identify opportunities to involve other healthcare providers to help facilitate the deprescribing process.
- 5.6Module 5 Reference List
- Module 6: Implement the Deprescribing PlanCan add a section description here7
- 6.1Learning Objective 1: Describe how to monitor the patient through the deprescribing process to determine the outcome of deprescribing.
- 6.2Learning Objective 2: Determine if/when the medication should be restarted.
- 6.3Learning Objective 3: Describe strategies for supporting patients during the deprescribing process.
- 6.4Learning Objective 4: Identify opportunities to involve, communicate, and develop collaborative relationships with other healthcare providers during the deprescribing process.
- 6.5Learning Objective 5: Identify strategies to implement deprescribing into daily practice.
- 6.6Learning Objective 6: Self-assess your knowledge and skills related to the various steps involved in deprescribing.
- 6.7Module 6 Reference List
